Jaguar Health Inc (JAGX)

[realfast95]

On September 25, 2020, Jaguar Health, Inc. (the “Company”) entered into a privately negotiated exchange agreement (the “Exchange Agreement”) with a holder of one of its outstanding secured promissory notes, which as described further below resulted in the aggregate issuance by the Company of more than 5% of the Company’s issued and outstanding shares of common stock (“Common Stock”), as last reported in the Company’s Quarterly Report on Form 10-Q filed on August 13, 2020.



From August 13, 2020 through September 25, 2020, the Company issued 4,761,904 shares of Common Stock in the following transactions:



On September 23, 2020, pursuant to an exchange agreement dated September 23, 2020, the Company issued 1,428,571 shares of Common Stock to a noteholder in exchange for a $500,000 reduction in the outstanding balance of the secured promissory note held by such noteholder.



On September 25, 2020, pursuant to an exchange agreement dated September 25, 2020, the Company issued 3,333,333 shares of Common Stock to a noteholder in exchange for a $1,000,000 reduction in the outstanding balance of the secured promissory note held by such noteholder.